Riseto Tablet (Risedronate Sodium)

Adult dose

1. Adults: Administer 35 mg of risedronate sodium orally once weekly. 2. Older adults: No dosage adjustment is necessary in older adults (over 60 years of age), because the bioavailability and pharmacodynamics of this medication are similar to those in younger people. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This medication is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. Food interferes with the absorption of this medication. To ensure adequate absorption, take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time of day. To help this medication reach the stomach easily and reduce the possibility of esophageal irritation, take it while upright with an adequate amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medication because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take the medication on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Children under 18 years of age: The safety and efficacy of this medication in children under 18 years of age have not been established.

This medication may irritate the mucosa of the upper gastrointestinal tract, so patients with esophageal disorders or issues such as gastritis, duodenitis, or ulcers should take it with caution. If symptoms like dysphagia, chest pain, or heartburn occur during use, discontinue immediately and consult a doctor. Take with sufficient water, and do not lie down for at least 30 minutes after taking it; understand and follow the dosing instructions accurately. Patients with esophageal strictures where the esophagus emptying is delayed, those with hypocalcemia, pregnant or nursing women, or those with severe renal impairment should not take this medication. Patients with Barrett's esophagus or gastrointestinal diseases, or those allergic to the ingredients of this medication should take it cautiously. This medication can cause side effects such as dyspepsia, abdominal pain, headache, joint pain, muscle pain, dizziness, skin rash, etc., and serious side effects such as severe esophageal damage or jaw osteonecrosis have been reported rarely. Before taking this medication, it is important to treat metabolic bone disorders such as hypocalcemia or vitamin D deficiency, and to get an adequate intake of calcium and vitamin D. To avoid interactions with other medications or food, do not take it with medications or foods containing calcium, magnesium, iron, etc., and maintain the timing and intervals of administration. It is preferable not to take this medication during pregnancy or breastfeeding, and consultation with a doctor is necessary when taking it. Safety and efficacy have not been established for children, so it is not used in this population. In case of overdose, symptoms of hypocalcemia may appear, requiring immediate medical attention for appropriate treatment. Keep this medication out of the reach of children and be cautious not to transfer it to another container.

• Esophagitis
• esophageal ulcer
• esophageal erosion
• esophageal obstruction
• esophageal perforation
• bleeding
• infection
• back pain
• accidental injury
• pain

This medication should be stored in a tightly sealed container to prevent air from entering and should be kept at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the medication's efficacy for a long time.

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets (2 tablets/PTP x 2)